FindTrial
Sign In

Randomized Comparative study of Pancreatinum 6c & Insulinum 6c in DM type II patients aged 30 to 75 years

Comparative study of Pancreatinum 6c & Insulinum 6c in DM type II patients aged 30 to 75 years – A randomized control trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065132
Enrollment
40
Registered
2024-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Insulinum 6c : Insulinum 6c 4 globules of 40 no. size BD before meals Control Intervention1: Pancreatinum 6c: Pancreatinum 6c 4 globules of 40 no size BD before meals

Sponsors

Dr Sukumar J Magdum Foundation Jaysingpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients taking Tab. Metformin orally for at least 3 months

Exclusion criteria

Exclusion criteria: 1. Immune-compromised patients 2. Pregnant females 3. Patients taking subcutaneous Inj. Insulin for DM –II

Design outcomes

Primary

MeasureTime frame
Change in Blood Glucose Level if anyTimepoint: Base line and every monthly for 3 months—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Padamavati Abhijeet Kumbhar

Late Mrs Housabai Homoeopathic Medical College and Hospital Nimshirgaon, MH

k.ashwin25@gmail.com8928981777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026